Plain-English translation of NCT06251635 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
Researchers know that olanzapine, an antipsychotic medication, can cause weight gain and blood sugar problems โ especially in women. This study uses brain imaging to see if olanzapine changes how your brain responds to insulin, and whether that response is different depending on where you are in your menstrual cycle. The goal is to understand why this medication affects metabolism differently in women than in men.
Antipsychotic medications help many people, but they often cause serious side effects like weight gain and diabetes, and women seem more vulnerable to these problems than men. Doctors don't yet understand exactly why this happens in the brain, so this research aims to fill that gap and potentially lead to better ways to prevent or manage these side effects.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will visit the research center four times over several months โ twice during the first half of your menstrual cycle and twice during the second half. At each visit, you'll take study medication (or placebo) for two days, then on day 3 you'll receive a nasal spray of insulin (or placebo) and undergo a brain MRI scan along with some cognitive tests. The entire study takes a few months to complete, and researchers will monitor you carefully throughout.
AI-generated summary from trial data ยท Jul 4, 2026 ยท Not medical advice
Canada